Lauer Technology (Wuhan) Ltd. will participate in The 20th CCBPC with its latest innovations, looking forward to witnessing more exciting developments in the field of critical care nephrology and blood purification together with all experts and colleagues.

Lauer Technology (Wuhan) Ltd. —wholly-owned by our CEO of Germany’s Dipl. Eng. Hans Guenter Lauer, was honored to take part in the 25th Congress of the Chinese Society of Nephrology (CCSN 2025), held recently in Zhengzhou.